Various analogues of adenosine have been described as inhibitors of S- adenosylhomocysteine (AdoHcy) hydrolase, and some of these AdoHcy hydrolase inhibitors (e.g., 3-deazaadenosine. 3-deazaaristeromycin, and 3- deazaneplanocin A) have also been reported to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). When evaluated against HIV-1 replication in MT-4 cells, macrophages, or phytohemagglutinin-stimulated peripheral blood lymphocytes infected acutely or chronically with HIV- 1(IIIB) or HIV(BaL) strains, a wide range of adenosine analogues did not inhibit HIV-1(IIIB) replication for 50% at subtoxic concentrations. However, they inhibited HIV-1 replication in HeLa CD4+ LTR-LacZ cells at concentrations well below cytotoxicity threshold. A close correlation was found among the inhibitory effect of the compounds on AdoHcy hydrolase activity, their inhibition of HIV-1 replication in Hela CD4+ LTR-LacZ cells, and their inhibition of the HIV-1 Tat-dependent and -independent transactivation of the long terminal repeat, whereas no inhibitory effect was seen on HIV-1 reverse transcription or a Tat-independent cytomegalovirus promoter. Our results suggest that AdoHcy hydrolase and the associated S- adenosylmethionine-dependent methylation mechanism play a role in the process of long terminal repeat transactivation and, hence, HIV replication.

Daelemans, D., Este, J., Witvrouw, M., Pannecouque, C., Jonckheere, H., Aquaro, S., et al. (1997). S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation. MOLECULAR PHARMACOLOGY, 52(6), 1157-1163.

S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation

PERNO, CARLO FEDERICO;
1997-01-01

Abstract

Various analogues of adenosine have been described as inhibitors of S- adenosylhomocysteine (AdoHcy) hydrolase, and some of these AdoHcy hydrolase inhibitors (e.g., 3-deazaadenosine. 3-deazaaristeromycin, and 3- deazaneplanocin A) have also been reported to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). When evaluated against HIV-1 replication in MT-4 cells, macrophages, or phytohemagglutinin-stimulated peripheral blood lymphocytes infected acutely or chronically with HIV- 1(IIIB) or HIV(BaL) strains, a wide range of adenosine analogues did not inhibit HIV-1(IIIB) replication for 50% at subtoxic concentrations. However, they inhibited HIV-1 replication in HeLa CD4+ LTR-LacZ cells at concentrations well below cytotoxicity threshold. A close correlation was found among the inhibitory effect of the compounds on AdoHcy hydrolase activity, their inhibition of HIV-1 replication in Hela CD4+ LTR-LacZ cells, and their inhibition of the HIV-1 Tat-dependent and -independent transactivation of the long terminal repeat, whereas no inhibitory effect was seen on HIV-1 reverse transcription or a Tat-independent cytomegalovirus promoter. Our results suggest that AdoHcy hydrolase and the associated S- adenosylmethionine-dependent methylation mechanism play a role in the process of long terminal repeat transactivation and, hence, HIV replication.
1997
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
English
LONG TERMINAL REPEAT; CHRONICALLY INFECTED MACROPHAGES; TRANS-ACTIVATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; ANTIVIRAL ACTIVITY; CELLS; HIV; 3-DEAZAADENOSINE; SPECTRUM
Daelemans, D., Este, J., Witvrouw, M., Pannecouque, C., Jonckheere, H., Aquaro, S., et al. (1997). S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation. MOLECULAR PHARMACOLOGY, 52(6), 1157-1163.
Daelemans, D; Este, J; Witvrouw, M; Pannecouque, C; Jonckheere, H; Aquaro, S; Perno, Cf; De Clercq, E; Vandamme, A
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
S adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.pdf

accesso aperto

Licenza: Creative commons
Dimensione 229.86 kB
Formato Adobe PDF
229.86 kB Adobe PDF Visualizza/Apri

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/57589
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact